VaxSeer: How MIT’s AI Innovation is Revolutionizing Flu Vaccine Development By EV • Post Published Sept 3, 2025 Every year, global public health experts face a daunting challenge: selecting the influenza virus strains to be included in the upcoming seasonal flu vaccine. This high-stakes decision must be made months in advance, as vaccine manufacturing and…
Nvidia Stock Faces Cooling Despite Robust AI Chip Demand By EV • Post Published Sept 2, 2025 Nvidia Corporation, a global leader in AI hardware, has encountered a notable shift in investor sentiment despite posting exceptional financial results in its latest quarterly earnings. The company reported $46.7 billion in revenue for its second fiscal quarter ended July 27, 2025—a 56% year-over-year increase—and a sequential growth of 6%. This…
MIT Report Finds 95% of Firms Incorporating AI See No Returns, Highlighting Adoption Challenges By EV • Post Published Aug 25, 2025 A recent study from the Massachusetts Institute of Technology (MIT) has revealed a sobering reality for the corporate world’s AI ambitions: 95% of firms investing in AI tools and generative AI initiatives have…